N.N. Blokhin Russian Cancer Research Center, skin tumor department
Welcome,         Profile    Billing    Logout  
 0 Trials 
7 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Samoylenko, Igor
NCT05578820: Safety, Tolerability and Pharmacokinetics Investigation of Stimotimagene Copolymerplasmid

Completed
1
21
RoW
Stimotimagene copolymerplasmid, AntioncoRAN-M, Ganciclovir, Cymeven®
Gene Surgery LLC
Sarcoma, Melanoma, Squamous Cell Carcinoma of Head and Neck, Breast Neoplasms, Uterine Cervical Neoplasms, Vulvar Neoplasms, Penile Neoplasms, Anus Neoplasms
04/24
04/24
CRISTINA, NCT06299878: MelPRO-0322 ( Trial) [miCrobiome pRedIctS aPD1 effecTivnes In melaNoma pAtietns]

Recruiting
N/A
72
RoW
Gut microbiota analysis
Russian Academy of Medical Sciences
Melanoma, Skin, Melanoma Stage Iii
12/24
07/25
ICIPRESIST19, NCT04025424: Genetic Predictors of Efficiency and Safety of ICIs in Patients With Different Malignancies (ICIPRESIST-0519)

Recruiting
N/A
350
RoW
Genetic tests of the available tumor and plasma samples
Russian Academy of Medical Sciences
Melanoma, Squamous Cell Lung Cancer, Uveal Melanoma, Hodgkin Lymphoma
06/22
12/23
MoleMed, NCT04353050: Atypical MOLes and Melanoma Early Detection Study

Recruiting
N/A
350
RoW
Non-invasive adhesive system (patch)
Russian Academy of Medical Sciences, Blokhin's Russian Cancer Research Center
Melanoma, Melanoma (Skin), Moles, Nevus, Nevus, Blue, Nevus, Pigmented, Nevus, Spitz, Nevi, Spindle Cell, Nevi, Dysplastic, Dysplastic Nevus Syndrome, Mucosal Melanoma, Mucosal Melanosis
01/23
11/23
CAMELLIA, NCT05402046: Clinical vAlidation of a MobilE appLication ("ProRodinki") in the Assessment of the maLignant skIn neoplAsms

Recruiting
N/A
605
RoW
Mobile phone application "ProRodinki"
MelanomaPRO, Russia, Privolzhsky Research Medical University
Melanoma (Skin), Nevus, Nevus, Spitz, Nevus Halo, Nevus, Pigmented, Basal Cell Carcinoma, Squamous Cell Carcinoma, Bowen's Disease, Melanoma in Situ, Spot Pigmented
04/23
04/24
RATIONALE, NCT05171374: pRospective Evaluation of Clinical Outcomes in Patients With metAsTatIс melanOma Treated With dabrafeNib and trAmetinib in reaL practicE

Recruiting
N/A
500
RoW
Dabrafenib, Trametinib
MelanomaPRO, Russia, Novartis
Melanoma Stage III, Melanoma Stage IV, Melanoma
09/23
09/24
ISABELLA, NCT05402059: Clinical Outcomes and Biomarkers in Patients With Stage 0-IV Melanoma in Real Clinical Practice

Recruiting
N/A
1570
RoW
surgery (any volume) and / or pharmaceuticals treatment initiated or planned or only dynamic observation, in accordance with current clinical guidelines
MelanomaPRO, Russia
Melanoma, Melanoma (Skin), Melanoma, Uveal, Melanoma Stage IV, Melanoma Stage III, Melanoma, Stage II, Melanoma in Situ, Melanoma, Ocular
04/24
04/25

Download Options